Rare tumor study reveals treatment insights
NCT ID NCT04365023
First seen Feb 25, 2026 · Last updated Jun 16, 2026 · Updated 14 times
Summary
This study looked at medical records of 168 people with a rare type of digestive cancer called well-differentiated grade 3 neuroendocrine tumors. The goal was to compare how well different chemotherapy treatments work and to learn more about how the disease progresses. No new treatments were tested; instead, researchers gathered information to better understand these tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gastroenterology and digestive oncology unit - Cochin hospital
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.